What’s in the Pipeline for Melasma and Vitiligo

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-81-322-3664-1_33
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinico-epidemiological Study and Quality of Life Assessment in Melasma

  2015cited by this paper
• Characteristic dermoscopic features of melasma.

  2015cited by this paper
• The effect of latanoprost on vitiligo: a preliminary comparative study

  2015cited by this paper
• Efficacy and Safety of Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream in Chinese Patients with Melasma: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study

  2015cited by this paper
• Variable pulsed light treatment of melasma and post-inflammatory hyperpigmentation – A pilot study

  2015cited by this paper
• Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study

  2015cited by this paper
• Low‐fluence Q‐switched Nd: YAG 1064‐nm laser and intense pulsed light for the treatment of melasma

  2015cited by this paper
• Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.

  2015cited by this paper
• The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial

  2015cited by this paper
• A prospective, split-face, randomized study of the efficacy and safety of a novel fractionated intense pulsed light treatment for melasma in Asians

  2015cited by this paper
• Copper Bromide Laser vs Triple-Combination Cream for the Treatment of Melasma: A Randomized Clinical Trial.

  2015cited by this paper
• Tranexamic Acid Diminishes Laser-Induced Melanogenesis

  2015cited by this paper
• The efficacy of tranexamic acid in the treatment of melasma

  2015cited by this paper
• Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double‐blind placebo‐controlled trial

  2015cited by this paper
• A Randomized Comparative Study of Oral Corticosteroid Minipulse and Low-Dose Oral Methotrexate in the Treatment of Unstable Vitiligo

  2015cited by this paper
• Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy

  2015cited by this paper
• Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma

  2015cited by this paper
• Effectiveness of low-fluence and short-pulse intense pulsed light in the treatment of melasma: A randomized study

  2015cited by this paper
• Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial.

  2015cited by this paper
• Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy.

  2015cited by this paper
• New insight in the treatment of refractory melasma: Laser Q‐switched Nd: YAG non‐ablative fractionated followed by intense pulsed light

  2015cited by this paper
• A double‐blind vehicle‐controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of melasma in females

  2014cited by this paper
• CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo

  2014cited by this paper
• Novel topical cream delivers safe and effective sunlight therapy for vitiligo by selectively filtering damaging ultraviolet radiation

  2014cited by this paper
• Therapeutic outcome of melasma treatment by dual‐wavelength (511 and 578 nm) laser in patients with skin phototypes III–V

  2014cited by this paper
• A randomized, split‐face clinical trial of low‐fluence Q‐switched neodymium‐doped yttrium aluminum garnet (1,064 nm) laser versus low‐fluence Q‐switched alexandrite laser (755 nm) for the treatment of facial melasma

  2014cited by this paper
• In vitro evaluation of a novel topical cream for vitiligo and psoriasis that selectively delivers NB‐UVB therapy when exposed to sunlight

  2014cited by this paper
• Role of oxidative stress in the pathogenesis of vitiligo with special emphasis on the antioxidant action of narrowband ultraviolet B phototherapy

  2014cited by this paper
• Hydroquinone-salicylic acid conjugates as novel anti-melasma actives show superior skin targeting compared to the parent drugs.

  2014cited by this paper
• Topical tranexamic acid as a promising treatment for melasma

  2014cited by this paper
• Near‐visible light and UV photoprotection in the treatment of melasma: a double‐blind randomized trial

  2014cited by this paper
• Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study

  2014cited by this paper
• Immunology and skin in health and disease.

  2014cited by this paper
• Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris.

  2014cited by this paper
• Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo

  2014cited by this paper
• What's new in objective assessment and treatment of facial hyperpigmentation?

  2014cited by this paper
• Regression of Melasma with Platelet-Rich Plasma Treatment

  2014cited by this paper
• A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner’s solution in melasma patients

  2014cited by this paper
• Reduction of facial pigmentation of melasma by topical lignin peroxidase: A novel fast-acting skin-lightening agent

  2014cited by this paper
• Low-Power Fractional CO2 Laser Versus Low-Fluence Q-Switch 1,064 nm Nd:YAG Laser for Treatment of Melasma: A Randomized, Controlled, Split-Face Study

  2014cited by this paper
• Pulse in Pulse Intense Pulsed Light for Melasma Treatment: A Pilot Study

  2014cited by this paper
• Combination of fractional erbium-glass laser and topical therapy in melasma resistant to triple-combination cream

  2014cited by this paper
• Combined Use of Monopolar Radiofrequency and Transdermal Drug Delivery in the Treatment of Melasma

  2014cited by this paper
• Preliminary Comparison of Fractional Laser with Fractional Laser Plus Radiofrequency for the Treatment of Acne Scars and Photoaging

  2014cited by this paper
• Combination Treatment of Low-Fluence 1,064-nm Q-Switched Nd: YAG Laser With Novel Intense Pulse Light in Korean Melasma Patients A Prospective, Randomized, Controlled Trial

  2014cited by this paper
• A randomized, double‐blind, placebo‐controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos

  2014cited by this paper
• Whitening efficacy of plant extracts including Hippophae rhamnoides and Cassia fistula extracts on the skin of Asian patients with melasma

  2013cited by this paper
• Effect of tranexamic acid on melasma: a clinical trial with histological evaluation

  2013cited by this paper
• The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.

  2013cited by this paper
• Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.

  2013cited by this paper
• Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser

  2013cited by this paper
• In vivo reflectance confocal microscopy for skin imaging in melasma.

  2013cited by this paper
• Successful treatment of hydroquinone‐resistant melasma using topical methimazole

  2013cited by this paper
• Oral Tranexamic Acid Enhances the Efficacy of Low‐Fluence 1064‐Nm Quality‐Switched Neodymium‐Doped Yttrium Aluminum Garnet Laser Treatment for Melasma in Koreans: A Randomized, Prospective Trial

  2013cited by this paper
• Potential advantages of simvastatin as a novel anti-vitiligo arsenal.

  2013cited by this paper
• The use of ablative lasers in the treatment of facial melasma*

  2013cited by this paper
• A retrospective study of the management of Chinese melasma patients using a 1927 nm fractional thulium fiber laser

  2013cited by this paper
• Treatment of vitiligo with a chimeric monoclonal antibody to CD20: a pilot study

  2013cited by this paper
• Melasma pathogenesis and influencing factors – an overview of the latest research

  2013cited by this paper
• A Randomised, Open-label, Comparative Study of Tranexamic Acid Microinjections and Tranexamic Acid with Microneedling in Patients with Melasma

  2013cited by this paper
• Treatment of Melasma With Oral Administration of Tranexamic Acid

  2012cited by this paper
• Application of in vivo reflectance confocal microscopy in melasma classification.

  2012cited by this paper
• A single‐blinded comparative study between the use of glycolic acid 70% peel and the use of topical nanosome vitamin C iontophoresis in the treatment of melasma

  2012cited by this paper
• The treatment of melasma by silymarin cream

  2012cited by this paper
• In vivo reflectance confocal microscopy in a typical case of melasma.

  2012cited by this paper
• Comparative study of 15% TCA peel versus 35% glycolic acid peel for the treatment of melasma

  2012cited by this paper
• Topical 5% tranexamic acid for the treatment of melasma in Asians: A double-blind randomized controlled clinical trial

  2012cited by this paper
• Successful treatment of melasma using a combination of microdermabrasion and Q‐switched Nd:YAG lasers

  2012cited by this paper
• Anti-inflammatory and monocyte-suppressing effects of simvastatin in patients with impaired fasting glucose.

  2011cited by this paper
• Skin Needling to Enhance Depigmenting Serum Penetration in the Treatment of Melasma

  2011cited by this paper
• Efficacy of a novel hydroquinone‐free skin‐brightening cream in patients with melasma

  2011cited by this paper
• A comparative study of the safety and efficacy of 75% mulberry (Morus alba) extract oil versus placebo as a topical treatment for melasma: a randomized, single-blind, placebo-controlled trial.

  2011cited by this paper
• A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+ T cell accumulation in the skin

  2011cited by this paper
• A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma

  2011cited by this paper
• Ethosomes® and transfersomes® containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders

  2011cited by this paper
• Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study.

  2011cited by this paper
• Efficacy of 694‐nm Q‐Switched Ruby Fractional Laser Treatment of Melasma in Female Korean Patients

  2011cited by this paper
• Sequential Treatment with Triple Combination Cream and Intense Pulsed Light is More Efficacious than Sequential Treatment with an Inactive (Control) Cream and Intense Pulsed Light in Patients with Moderate to Severe Melasma

  2011cited by this paper
• Successful treatment of malar dermal melasma with a fractional ablative CO2 laser in a patient with type V skin

  2010cited by this paper
• Characterization and evaluation of pigment distribution and response to therapy in melasma using in vivo reflectance confocal microscopy: a preliminary study

  2010cited by this paper
• Methotrexate: from its introduction to non-oncologic therapeutics to anti-TNF-α.

  2010cited by this paper
• Impact of long-wavelength UVA and visible light on melanocompetent skin.

  2010cited by this paper
• Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo

  2009cited by this paper
• Minocycline protects melanocytes against H2O2-induced cell death via JNK and p38 MAPK pathways.

  2008cited by this paper
• Bimatoprost-induced periocular skin hyperpigmentation: histopathological study.

  2005cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin C Iontophoresis in Melasma

  2003cited by this paper
• The Expression of α‐MSH by Melanocytes Is Reduced in Vitiligo

  1999cited by this paper
• Association of the koebner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris

  1998cited by this paper
• In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo.

  1995cited by this paper
• Lyme Disease

  1990cited by this paper
• Pathogenesis and treatment of vitiligo

  1973cited by this paper

• Comparative Study between Topical Flutamide Alone or Combined with Carboxytherapy in Treatment of Patients with Melasma

  2019cites this paper
• A comparative study between two topical treatments (tranexamic acid and flutamide) in the treatment of patients with melasma

  2018cites this paper
• Considerations When Treating Cosmetic Concerns in Men of Color

  2017cites this paper